Beyond that, some research showed that the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA, Figure 2) remarkably inhibited cell viability and proliferation, induced cell apoptosis in EGFR-mutant lung cancer cell lines [25,26]. This evidence concerns the gene EGFR and lung cancer.